A study in the journal Nature Immunology showed that a T-cell with a receptor targeting the MR1 molecule was able to destroy blood, breast, bone, cervical, colon, kidney, lung, ovarian, prostate and skin cancer cells without affecting normal tissues. The findings suggest that the approach may be used in treating all cancers but more studies are still needed, researchers said.
Novel T-cell may be used in treating various cancers
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.